Advertisement

Topics

Latest "Avedro, Inc." News Stories

12:48 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Avedro, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Avedro, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Avedro, Inc. for you to read. Along with our medical data and news we also list Avedro, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Avedro, Inc. Companies for you to search.

Showing "Avedro" News Articles, all 11

Wednesday 6th February 2019

Ophthalmic device company Avedro plans $75M IPO

Ophthalmic medical systems company Avedro will offer 5 million shares at $14 to $16 each in hopes of raising $75 million in i -More- 


Tuesday 5th February 2019

IPO Update: Avedro Files Proposed Terms For IPO

Tuesday 22nd January 2019

Avedro Starts U.S. IPO Effort


Avedro IPO: Speculative, But With An Ongoing Phase 3 Clinical Trial

Monday 21st January 2019

Avedro looks to launch $86M public offering

A prospectus has been filed by Avedro for an initial public offering in hopes of raising $86 million. -More- 

Tuesday 11th December 2018

Anthem Blue Cross Blue Shield Joins List of 60 Commercial Plans Covering Avedro’s FDA-Approved Corneal Cross-Linking Procedure

Cross-linking now covered by the top five largest commercial insurance companies Avedro, Inc., a leading commercial-stage ophthalmic medical technology company and a global leader in corneal remodeling, today announced that Anthem, the largest member of the Blue Cross Blue Shield Association, has issued a positive coverage policy for Avedro’s ...

Tuesday 20th November 2018

Permanent J Code Issued for Avedro’s Photrexa® Drug Formulations

J Code 2787, Effective January 1, 2019, Expected to Streamline Reimbursement and Expand Patient Access Avedro, Inc., a leading commercial-stage ophthalmic medical technology company and a global leader in corneal remodeling, today announced that the Centers for Medicare and Medicaid Services (CMS) issued a product-specific J code, J278...

Saturday 27th October 2018

Avedro Inc Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryAvedro Inc Averdro is a medical device company that manufactures and distributes crosslinking systems and riboflavin ophthalmic products. The company's products include mosaic systems for PiXL, lasik xtra, and accelerated crosslinking; KXL systems for lasik xtra and accelerated crosslinking; IROC Innocross for ocular pathology; and riboflavin formulations for various crosslinking needs. It ...

Wednesday 17th October 2018

Avedro Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryAvedro Inc Averdro is a medical device company that manufactures and distributes crosslinking systems and riboflavin ophthalmic products. The company's products include mosaic systems for PiXL, lasik xtra, and accelerated crosslinking; KXL systems for lasik xtra and accelerated crosslinking; IROC Innocross for ocular pathology; and riboflavin formulations for various crosslinking needs. It ...

Monday 8th October 2018

Global Presbyopia Correction Devices Market Status and Outlook 20182025 [Report Updated: 13082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Tuesday 25th September 2018

Cigna Is Newest Payer to Join Growing List of Commercial Plans Covering Avedro’s FDA-Approved Cross-Linking Procedure—133 Million Lives Covered in Total

Avedro Names Tim Homer Vice President of Health Policy & Market Access in Continued Effort to Expand Market Access and Reimbursement of Cross-Linking Avedro, Inc., an ophthalmic pharmaceutical and medical device company and world leader in corneal remodeling, today announced that 50 commercial insurance plans now cover Avedro’s


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks